Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuo Tani

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Expert Opinion on Therapeutic Targets|March 11, 2021
KRAS G12C inhibition and innate immune targetingTetsuo Tani, Shunsuke Kitajima, Ella B Conway, et al.
Sleep & Breathing = Schlaf & Atmung|July 8, 2019
Factors associated with improvements in subjective symptoms of obstructive sleep apnea syndrome after continuous positive airway pressure therapyKengo Otsuka, Koichi Fukunaga, WakakoYamasawa, et al.
Molecular and Clinical Oncology|February 18, 2020
Outcome of patients with lung cancer and severe psychiatric disorder admitted to a medical psychiatric unitTomohiro Takehara, Tetsuo Tani, Hiroyuki Takiue, et al.
Case Reports in Pulmonology|July 1, 2015
A Case of Disseminated Cryptococcal Infection and Concurrent Lung Tuberculosis in a Patient under Steroid Therapy for Interstitial PneumoniaAoi Kuroda, Sadatomo Tasaka, Kazuma Yagi, et al.
International Journal of Oncology|October 30, 2014
Multiple roles of extracellular fibroblast growth factors in lung cancer cellsTakahiro Suzuki, Hiroyuki Yasuda, Koji Funaishi, et al.
Molecular and Clinical Oncology|October 5, 2016
Successful treatment of non-small-cell lung cancer with afatinib and a glucocorticoid following gefitinib- and erlotinib-induced interstitial lung disease: A case reportTetsuo Tani, Katsuhiko Naoki, Takanori Asakura, et al.
Molecular Cancer Therapeutics|June 30, 2019
Monomer Preference of EGFR Tyrosine Kinase Inhibitors Influences the Synergistic Efficacy of Combination Therapy with CetuximabAyano Oashi, Hiroyuki Yasuda, Keigo Kobayashi, et al.
Cancer Chemotherapy and Pharmacology|September 8, 2019
A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patientsTetsuo Tani, Katsuhiko Naoki, Hiroyuki Yasuda, et al.
Molecular Cancer Therapeutics|December 20, 2015
Activation of EGFR Bypass Signaling by TGFα Overexpression Induces Acquired Resistance to Alectinib in ALK-Translocated Lung Cancer CellsTetsuo Tani, Hiroyuki Yasuda, Junko Hamamoto, et al.
Cancer Management and Research|October 7, 2021
Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung CancerTetsuo Tani, Ichiro Nakachi, Shinnosuke Ikemura, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Expert Opinion on Therapeutic Targets|March 11, 2021
KRAS G12C inhibition and innate immune targetingTetsuo Tani, Shunsuke Kitajima, Ella B Conway, et al.
Sleep & Breathing = Schlaf & Atmung|July 8, 2019
Factors associated with improvements in subjective symptoms of obstructive sleep apnea syndrome after continuous positive airway pressure therapyKengo Otsuka, Koichi Fukunaga, WakakoYamasawa, et al.
Molecular and Clinical Oncology|February 18, 2020
Outcome of patients with lung cancer and severe psychiatric disorder admitted to a medical psychiatric unitTomohiro Takehara, Tetsuo Tani, Hiroyuki Takiue, et al.
Case Reports in Pulmonology|July 1, 2015
A Case of Disseminated Cryptococcal Infection and Concurrent Lung Tuberculosis in a Patient under Steroid Therapy for Interstitial PneumoniaAoi Kuroda, Sadatomo Tasaka, Kazuma Yagi, et al.
International Journal of Oncology|October 30, 2014
Multiple roles of extracellular fibroblast growth factors in lung cancer cellsTakahiro Suzuki, Hiroyuki Yasuda, Koji Funaishi, et al.
Molecular and Clinical Oncology|October 5, 2016
Successful treatment of non-small-cell lung cancer with afatinib and a glucocorticoid following gefitinib- and erlotinib-induced interstitial lung disease: A case reportTetsuo Tani, Katsuhiko Naoki, Takanori Asakura, et al.
Molecular Cancer Therapeutics|June 30, 2019
Monomer Preference of EGFR Tyrosine Kinase Inhibitors Influences the Synergistic Efficacy of Combination Therapy with CetuximabAyano Oashi, Hiroyuki Yasuda, Keigo Kobayashi, et al.
Cancer Chemotherapy and Pharmacology|September 8, 2019
A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patientsTetsuo Tani, Katsuhiko Naoki, Hiroyuki Yasuda, et al.
Molecular Cancer Therapeutics|December 20, 2015
Activation of EGFR Bypass Signaling by TGFα Overexpression Induces Acquired Resistance to Alectinib in ALK-Translocated Lung Cancer CellsTetsuo Tani, Hiroyuki Yasuda, Junko Hamamoto, et al.
Cancer Management and Research|October 7, 2021
Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung CancerTetsuo Tani, Ichiro Nakachi, Shinnosuke Ikemura, et al.
Pageof 5